2016 & Earlier
Dragset MS, Barczak AK, Flo TH, Valla S, Rubin EJ, Steigedal M. Benzoic acid-inducible gene expression in mycobacteria. PloS One, 2015 Sep 8; 10(9):e0134544.
Kieser KJ, Kester JC, Boutte CC, Meniche X, Barczak AK, Rego EH, Sassetti CM, Fortune SM, Rubin EJ. Phosphorylation of the peptidoglycan synthase ponA1 governs the rate of polar elongation in mycobacteria. PLoS Pathog 2015 Jun; 11(6):e1005010.
Stanley SA*, Barczak AK*, Silvis MR, Luo SS, Sogi KM, Volkes M, Bray MA, Carpenter AE, Siddiqi N, Rubin EJ, Hung DT. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog 2014 Feb; 10(2): e1003946. *contributed equally
Barczak AK*, Gomez JE*, Kaufmann BB, Hinson ER, Cosimi L, Borowsky ML, Onderdonk AB, Stanley SA, Kaur D, Bryant KF, Knipe DM, Sloutsky A, Hung DT. (2012) RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities. Proc Natl Acad Sci USA, 109(16):6217-22. *contributed equally
Barczak AK, Hung DT (2009). Productive steps toward an antimicrobial targeting virulence. Curr Opin Microbiol. 12(5):490-6.
Manca C, Tsenova L, Freeman S, Barczak AK, Tovey M, Murray PJ, Barry C, Kaplan G. (2005) Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res 11, 694-701.
Barczak AK, Domenech P, Boshoff HI, Reed MB, Manca C, Kaplan G, Barry CE 3rd. (2005) In vivo phenotypic dominance in mouse mixed infections with Mycobacterium tuberculosis clinical isolates. J Infect Dis 192, 600-6.
Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, Kaplan G, Barry CE 3rd. (2004) A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431, 84-7.
Barthel R, Tsytsykova AV, Barczak AK, Tsai EY, Dascher CC, Brenner MB, Goldfeld AE. (2003) Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol Cell Biol 23, 526-33.
Dudman JT, Eaton ME, Rajadhyaksha A, Macias W, Taher M, Barczak A, Kameyama K, Huganir R, Konradi C. (2003) Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem 87, 922-34.
Macias W, Carlson R, Rajadhyaksha A, Barczak A, Konradi C. (2001) Potassium chloride depolarization mediates CREB phosphorylation in striatal neurons in an NMDA receptor-dependent manner. Brain Res 890, 222-32.
Tsai EY, Falvo JV, Tsytsykova AV, Barczak AK, Reimold AM, Glimcher LH, Fenton MJ, Gordon DC, Dunn IF, Goldfeld AE. (2000) A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol 20, 6084-94.
Leveque JC, Macias W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S, Li XM, Coyle JT, Huganir RL, Heckers S, Konradi C. (2000) Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci 20, 4011-20.
Rajadhyaksha A, Barczak A, Macias W, Leveque JC, Lewis SE, Konradi C. (1999) L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J Neurosci 19, 6348-59.
Luthi-Carter R, Barczak AK, Speno H, Coyle JT. (1998) Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Pharmacol Exp Ther 286,1020-5.
Rajadhyaksha A, Leveque J, Macias W, Barczak A, Konradi C. (1998) Molecular components of striatal plasticity: the various routes of cyclic AMP pathways. Dev Neurosci 20, 204-15
Luthi-Carter R, Barczak AK, Speno H, Coyle JT. (1998) Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II. Brain Res 795, 341-8.
Luthi-Carter R, Berger UV, Barczak AK, Enna M, Coyle JT. (1998) Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. Proc Natl Acad Sci U S A 95, 3215-20